
PMC:7441788 / 15813-15917
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T98","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T205","span":{"begin":91,"end":102},"obj":"Chemical"}],"attributes":[{"id":"A205","pred":"chebi_id","subj":"T205","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-sample-CHEBI
{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T126","span":{"begin":91,"end":102},"obj":"Chemical"}],"attributes":[{"id":"A126","pred":"chebi_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-sample-PD-NCBITaxon
{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T101","span":{"begin":30,"end":38},"obj":"Species"}],"attributes":[{"id":"A101","pred":"ncbi_taxonomy_id","subj":"T101","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-sample-sentences
{"project":"LitCovid-sample-sentences","denotations":[{"id":"T116","span":{"begin":45,"end":53},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-sample-Pubtator
{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"733","span":{"begin":91,"end":102},"obj":"Chemical"},{"id":"767","span":{"begin":16,"end":24},"obj":"Species"},{"id":"780","span":{"begin":1,"end":15},"obj":"Disease"},{"id":"781","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A733","pred":"pubann:denotes","subj":"733","obj":"MESH:D002738"},{"id":"A767","pred":"pubann:denotes","subj":"767","obj":"Tax:9606"},{"id":"A780","pred":"pubann:denotes","subj":"780","obj":"MESH:D016638"},{"id":"A781","pred":"pubann:denotes","subj":"781","obj":"MESH:C000657245"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-sample-PD-MONDO
{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T91","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A91","pred":"mondo_id","subj":"T91","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"733","span":{"begin":91,"end":102},"obj":"Chemical"},{"id":"767","span":{"begin":16,"end":24},"obj":"Species"},{"id":"780","span":{"begin":1,"end":15},"obj":"Disease"},{"id":"781","span":{"begin":30,"end":38},"obj":"Disease"}],"attributes":[{"id":"A733","pred":"tao:has_database_id","subj":"733","obj":"MESH:D002738"},{"id":"A767","pred":"tao:has_database_id","subj":"767","obj":"Tax:9606"},{"id":"A780","pred":"tao:has_database_id","subj":"780","obj":"MESH:D016638"},{"id":"A781","pred":"tao:has_database_id","subj":"781","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T116","span":{"begin":45,"end":53},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" critically ill patients with COVID-19 [49].\nTable 1. Outcomes and advantage/limitation of chloroquine ("}